MedTrace Logo

Caffeine as Respiratory Stimulant in Preterm Infants

NCT04144712 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-02-07

No results posted yet for this study

Summary

comparison between rate of occurance of apnea of prematurity AOP when using high and low dose caffeine

Conditions

  • Apnea of Prematurity

Interventions

DRUG

Caffeine Citrate

study rate of occurrence of Apnea of Prematurity between the 2 groups

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Yasmin A Farid, MD · Pediatric Department Faculty of Medicine Ain shams University

  • Ola G Badr El-Deen, MD · Pediatric Department Faculty of Medicine Ain shams University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Max Age
10 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2020-10-31
Completion
2020-11-30
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04144712 on ClinicalTrials.gov